CR HOLDINGS (01911) subsidiary successfully assisted AI inference token provider SiliconFlow in completing the second tranche of its Series B+ and Series C financing.
CR HOLDINGS (01911) announced that its wholly-owned subsidiary CR Pan-Asia Investment Advisors (Beijing) Co., Ltd. (CR Pan-Asia) acted as the exclusive financial advisor and successfully assisted Beijing SiliconFlow Technology Co., Ltd. (SiliconFlow) in completing the second tranche of its Series B+ and Series C financing.
CR HOLDINGS (01911) announced that its wholly-owned subsidiary, China Renaissance Pan-Asia Investment Advisors (Beijing) Co., Ltd. (China Renaissance Pan-Asia), acted as sole financial advisor and successfully assisted Beijing SiliconFlow Technology Co., Ltd. (SiliconFlow) in completing the second tranche of its Series B+ and Series C financing.
The above two rounds of financing received support from multiple types of investors, including national-level funds, investors with central and local state-owned backgrounds, industrial capital, and professional investment institutions, as well as follow-on investments from certain existing shareholders.
SiliconFlow is an artificial intelligence (AI) inference token provider, offering serverless token services, dedicated instances, and on-premises deployment solutions. Leveraging its independent and open platform positioning, leading inference optimization capabilities, and diversified product portfolio, SiliconFlow further expanded its commercial operating scale in the first half of 2026, with all of the above products and services growing rapidly, while its enterprise customers and overseas business also continued to expand.
The Group is honored to have assisted SiliconFlow in completing the above financing. This sole financial advisor appointment not only demonstrates the Group's deep professional financial advisory capabilities in the AI and high-tech sectors, but also reflects the Group's extensive business network covering the AI industry value chain, further confirming the Group's solid commitment to continuously empowering innovative growth-stage enterprises and helping them achieve strategic and financial milestones.
Related Articles

CHINAHEALTHWISE (00348) temporarily suspended trading from September 21 pending announcement of inside information.

PROSPEROUSPRINT (08385): Chen Kun Appointed as Authorized Representative

INSILICO(03696): Entered into an AI joint development collaboration with a contract value of up to tens of millions of US dollars to build and commercialize biological foundation models
CHINAHEALTHWISE (00348) temporarily suspended trading from September 21 pending announcement of inside information.

PROSPEROUSPRINT (08385): Chen Kun Appointed as Authorized Representative

INSILICO(03696): Entered into an AI joint development collaboration with a contract value of up to tens of millions of US dollars to build and commercialize biological foundation models

RECOMMEND





